Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Intestinal epithelial cell metabolism support" is not a specific molecule, receptor, or canonical therapeutic target. Instead, it refers broadly to the metabolic processes and functions of intestinal epithelial cells (IECs), which are critical for maintaining the intestinal barrier, regulating nutrient uptake, supporting immune tolerance, and interacting with the gut microbiota. IECs include various specialized cell types such as enterocytes, goblet cells, Paneth cells, enteroendocrine cells, tuft cells, and M cells. These functions are essential for digestive health and systemic homeostasis; disruption in their metabolism is implicated in diseases like inflammatory bowel disease and colorectal cancer[1][2]. However, "intestinal epithelial cell metabolism support" does not correspond to a single molecular entity or druggable target but rather describes a physiological process involving multiple pathways and cellular components.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal epithelial cell metabolism support.